NCT05589896 2026-02-24
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Phase 1/2 Recruiting
Ossium Health, Inc.
ARCE Therapeutics, Inc.
Nohla Therapeutics, Inc.
Mesoblast, Ltd.